vs

Side-by-side financial comparison of Kosmos Energy Ltd. (KOS) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Kosmos Energy Ltd. is the larger business by last-quarter revenue ($294.6M vs $225.6M, roughly 1.3× Organogenesis Holdings Inc.). On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs -25.9%). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs -16.5%).

Kosmos Energy is an American upstream oil company founded and based in Dallas, Texas. While previously incorporated in Bermuda, Kosmos has reincorporated in Delaware. The company holds production and development operations offshore Ghana, Equatorial Guinea, and Gulf of Mexico, while holding a development project offshore Mauritania and Senegal, and exploration licenses offshore Namibia, São Tomé and Príncipe and Suriname. It was previously involved in exploration offshore Morocco and Western ...

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

KOS vs ORGO — Head-to-Head

Bigger by revenue
KOS
KOS
1.3× larger
KOS
$294.6M
$225.6M
ORGO
Growing faster (revenue YoY)
ORGO
ORGO
+104.0% gap
ORGO
78.1%
-25.9%
KOS
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
-16.5%
KOS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KOS
KOS
ORGO
ORGO
Revenue
$294.6M
$225.6M
Net Profit
$43.7M
Gross Margin
Operating Margin
-125.7%
28.1%
Net Margin
19.4%
Revenue YoY
-25.9%
78.1%
Net Profit YoY
469.5%
EPS (diluted)
$-0.80
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KOS
KOS
ORGO
ORGO
Q4 25
$294.6M
$225.6M
Q3 25
$311.0M
$150.9M
Q2 25
$392.6M
$101.0M
Q1 25
$290.1M
$86.7M
Q4 24
$397.6M
$126.7M
Q3 24
$407.8M
$115.2M
Q2 24
$447.8M
$130.2M
Q1 24
$422.3M
$110.0M
Net Profit
KOS
KOS
ORGO
ORGO
Q4 25
$43.7M
Q3 25
$-124.3M
$21.6M
Q2 25
$-87.7M
$-9.4M
Q1 25
$-110.6M
$-18.8M
Q4 24
$7.7M
Q3 24
$45.0M
$12.3M
Q2 24
$59.8M
$-17.0M
Q1 24
$91.7M
$-2.1M
Gross Margin
KOS
KOS
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Q1 24
73.9%
Operating Margin
KOS
KOS
ORGO
ORGO
Q4 25
-125.7%
28.1%
Q3 25
-34.2%
13.7%
Q2 25
-16.2%
-12.5%
Q1 25
-32.4%
-30.9%
Q4 24
-8.5%
8.1%
Q3 24
26.1%
5.4%
Q2 24
30.2%
-10.7%
Q1 24
33.6%
-3.5%
Net Margin
KOS
KOS
ORGO
ORGO
Q4 25
19.4%
Q3 25
-40.0%
14.3%
Q2 25
-22.3%
-9.3%
Q1 25
-38.1%
-21.7%
Q4 24
6.1%
Q3 24
11.0%
10.7%
Q2 24
13.3%
-13.1%
Q1 24
21.7%
-1.9%
EPS (diluted)
KOS
KOS
ORGO
ORGO
Q4 25
$-0.80
$0.31
Q3 25
$-0.26
$0.11
Q2 25
$-0.18
$-0.10
Q1 25
$-0.23
$-0.17
Q4 24
$0.00
$0.05
Q3 24
$0.09
$0.09
Q2 24
$0.12
$-0.13
Q1 24
$0.19
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KOS
KOS
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$91.5M
$93.7M
Total DebtLower is stronger
$3.1B
Stockholders' EquityBook value
$528.6M
$300.1M
Total Assets
$4.7B
$598.7M
Debt / EquityLower = less leverage
5.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KOS
KOS
ORGO
ORGO
Q4 25
$91.5M
$93.7M
Q3 25
$64.0M
$63.7M
Q2 25
$51.7M
$73.1M
Q1 25
$49.8M
$110.0M
Q4 24
$85.0M
$135.6M
Q3 24
$51.6M
$94.3M
Q2 24
$173.8M
$89.9M
Q1 24
$254.3M
$88.6M
Total Debt
KOS
KOS
ORGO
ORGO
Q4 25
$3.1B
Q3 25
$3.0B
Q2 25
$2.9B
Q1 25
Q4 24
$2.7B
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
KOS
KOS
ORGO
ORGO
Q4 25
$528.6M
$300.1M
Q3 25
$898.8M
$255.1M
Q2 25
$1.0B
$233.2M
Q1 25
$1.1B
$242.9M
Q4 24
$1.2B
$262.9M
Q3 24
$1.2B
$278.5M
Q2 24
$1.1B
$263.5M
Q1 24
$1.1B
$278.0M
Total Assets
KOS
KOS
ORGO
ORGO
Q4 25
$4.7B
$598.7M
Q3 25
$5.1B
$509.8M
Q2 25
$5.2B
$461.1M
Q1 25
$5.3B
$467.4M
Q4 24
$5.3B
$497.9M
Q3 24
$5.5B
$446.3M
Q2 24
$5.4B
$443.2M
Q1 24
$5.4B
$458.5M
Debt / Equity
KOS
KOS
ORGO
ORGO
Q4 25
5.78×
Q3 25
3.31×
Q2 25
2.80×
Q1 25
Q4 24
2.29×
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KOS
KOS
ORGO
ORGO
Operating Cash FlowLast quarter
$35.3M
$39.4M
Free Cash FlowOCF − Capex
$34.8M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KOS
KOS
ORGO
ORGO
Q4 25
$35.3M
$39.4M
Q3 25
$-27.6M
$3.1M
Q2 25
$127.2M
$-32.9M
Q1 25
$-888.0K
$-19.9M
Q4 24
$175.7M
$10.9M
Q3 24
$6.3M
$8.7M
Q2 24
$223.7M
$4.7M
Q1 24
$272.6M
$-10.2M
Free Cash Flow
KOS
KOS
ORGO
ORGO
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
Q1 24
$-12.4M
FCF Margin
KOS
KOS
ORGO
ORGO
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Q1 24
-11.3%
Capex Intensity
KOS
KOS
ORGO
ORGO
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Q1 24
2.0%
Cash Conversion
KOS
KOS
ORGO
ORGO
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.14×
0.71×
Q2 24
3.74×
Q1 24
2.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KOS
KOS

Ghana Segment$134.6M46%
Gulf Of America$80.7M27%
Mauritania And Senegal$54.9M19%
Equatorial Guinea Segment$24.3M8%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons